Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection
about
Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An OverviewInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningStem cell imaging: from bench to bedsideInduced pluripotent stem cell (iPSCs) and their application in immunotherapyPI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem CellsResidual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitorsSafety of Autologous Bone Marrow Stromal Cell Transplantation in Dogs with Acute Spinal Cord InjuryThe combination of three-dimensional and rotary cell culture system promotes the proliferation and maintains the differentiation potential of rat BMSCs.Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapyThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsA mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissuesSnail1-dependent control of embryonic stem cell pluripotency and lineage commitmentInhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.Immunological barriers to stem-cell based cardiac repairBiology of the Mi-2/NuRD Complex in SLAC (Stemness, Longevity/Ageing, and Cancer).Comparative evaluation of differentiation potential of menstrual blood- versus bone marrow-derived stem cells into hepatocyte-like cells.Induced pluripotent stem cells are induced pluripotent stem cell-like cells.Teratoma formation: a tool for monitoring pluripotency in stem cell research.Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cellsTransplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival.Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1A promoter DNA demethylation landscape of human hematopoietic differentiation.Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton's Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells.Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart FailureA human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.How microRNAs facilitate reprogramming to pluripotency.The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps.Mitochondria in human pluripotent stem cell apoptosis.miR-302 regulates pluripotency, teratoma formation and differentiation in stem cells via an AKT1/OCT4-dependent manner.Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consentAlu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor.The Necessity of a Systematic Approach for the Use of MSCs in the Clinical SettingWharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.Concise review: mesenchymal stem cells and translational medicine: emerging issues.Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate
P2860
Q54749914-B8289FB4-47C0-41AF-935B-334EFB2FB7D8Q54749931-6602DDEA-BEC6-4667-A9A3-56953987EEF1Q54749932-6F7416D5-079C-4E16-BD27-90ED7BE5111AQ54896297-72597C0C-9E27-491B-ADA8-CD67A7EC2521Q54897105-D2E3AC87-BBF0-4305-AD49-F50DC0003512Q54898130-D11BDE04-7A09-4DA1-AE4B-C61C82B6A0E3Q54898131-C7550822-DE4B-4A10-A6FB-FE0540A9B48CQ54906904-9BAD4404-3225-425A-9178-F26C48547C6F
P1343
Q26770087-8DA10BC4-8A64-40BF-AF31-815403452B3BQ26828408-8D0BC2CB-B2A8-448B-B538-A0F1C986A8C4Q26861615-85F899BA-3DC7-49B3-BC9B-5B68BB49FE01Q26996540-212652FB-611A-4C06-AA4B-20F6F579DADFQ28551735-318DFCF7-D677-40A6-AA6F-D9ECEC902C40Q28730417-BA40B1C0-34E2-4D3C-A065-4C4F55780B56Q29395140-028DA901-0D79-4E3E-9F87-9DEBDD21C94AQ33671432-7D9CFF94-37AB-4454-A3AD-A74D2403B5DBQ33696606-3EEF1DBF-0290-4556-9FFB-219362A380BBQ33851544-F5FDFDD8-D2A0-4836-84C6-FD9204C7A3ABQ33911166-DE0E3E8A-4B6D-4D9C-9FF9-02028F8D36CEQ33972770-BB365DA7-90CC-47F1-9DE2-CBEF857A727EQ34232257-29BAB00F-1EBC-4620-9C77-8157EB02CFA4Q34382978-A1AA4AC6-34DD-4751-8B42-B4211C7E053EQ34482943-1DAEDBE8-147D-4BB8-AD38-22B611B98FB2Q34774684-CCEF13A5-0E1C-481C-A879-73D578A1884DQ34831528-42DE38C7-8A36-4C26-A2FE-B7513E04234AQ35088050-00568B12-B318-42D0-B61C-12DD35AB611AQ35126519-8ADD8418-2676-4B23-A7D1-A5D2B6E939BFQ35471418-E3432532-C894-4F71-B20D-286595A5EFF3Q35473934-A38022FA-F3EB-4CF7-9681-FD13EC830EDAQ35553469-E16FED6E-1423-4D01-93DF-D2E125084530Q35585501-1950C830-348C-47C1-859E-B893022EF277Q35633573-6C88B366-8B0D-4AC8-8728-A68DADC38FC1Q35659535-C543AF02-1ADB-41A9-83F8-961D51D162B2Q35865904-85F3E795-0BA1-4543-95BE-7C820587C534Q36009252-E5F8E1FF-C7A5-4791-B68C-4424F61F266FQ36085355-2DBA16BA-D0BE-4D0D-B66B-5B9677762282Q36379371-B0D42B30-534A-4916-8CC6-1A343D044A9AQ36451174-E52DBFCA-92DD-42B8-8B01-7B38B4CF33C1Q36557422-B599FC85-0CD0-4775-BA9D-E294ED652238Q36657651-7BBAC56E-EA0E-4AD5-8055-AFB2E4230708Q36723084-AE601367-7DDF-45CF-8A40-1A75838B2CD8Q36751720-2D9D25E7-BB20-4FDD-93DB-E2428E8DE6CBQ36861555-76DA2F43-7E45-4DB5-B17F-AED803B16D1AQ36958987-A87D27B4-850F-432E-945C-6C0D914272F7Q36995514-47427BA3-4F41-4D30-9ECE-0E29B17BAA5FQ37007214-B4F4D235-ECCA-4F20-BF15-F48410F87746Q37056276-9AB4BA47-69D6-4273-B102-2F34FA04913DQ37194210-37ECE744-F2F8-4B40-AEB9-2D6C10E4EC43
P2860
Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human induced pluripotent stem ...... gardless the site of injection
@ast
Human induced pluripotent stem ...... gardless the site of injection
@en
Human induced pluripotent stem ...... gardless the site of injection
@nl
type
label
Human induced pluripotent stem ...... gardless the site of injection
@ast
Human induced pluripotent stem ...... gardless the site of injection
@en
Human induced pluripotent stem ...... gardless the site of injection
@nl
prefLabel
Human induced pluripotent stem ...... gardless the site of injection
@ast
Human induced pluripotent stem ...... gardless the site of injection
@en
Human induced pluripotent stem ...... gardless the site of injection
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Human induced pluripotent stem ...... gardless the site of injection
@en
P2093
Angela Mácia
Clara Bueno
Gertrudis Ligero
Ivan Gutierrez-Aranda
Jose L Garcia-Parez
Laura Sanchez
Martin Munoz-Lopez
P2860
P304
P3181
P356
10.1002/STEM.471
P407
P577
2010-09-01T00:00:00Z